(Circulation. 2000;102:III-365.)
© 2000 American Heart Association, Inc.
Myocardial Protection and Vascular Biology |
From the Departments of Anesthesiology and Cardiac Surgery and the Anesthesia/Critical Care Medicine Laboratory, Childrens Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Francis X. McGowan, Jr, Cardiac Anesthesia Service, Childrens Hospital, 300 Longwood Ave, Boston, MA 02115. E-mail mcgowan_f{at}a1.tch.harvard.edu
BackgroundEndotoxin (lipopolysaccharide, LPS) is a trigger of the systemic inflammatory response. We have previously found that vesnarinone and amrinone, when given before LPS, prevented cytokine production and LPS-related cardiac dysfunction. We tested the hypothesis that vesnarinone would improve intracellular Ca2+ handling and calcium-activated contractile force after the onset of endotoxemia.
Methods and ResultsAdult rabbits received a bolus injection of
LPS or vehicle. Vesnarinone (3 mg/kg) was given
intravenously 90 minutes later. Two hours after LPS
administration, hearts were perfused in the isolated Langendorff mode.
Peak left ventricular developed pressure, ±dp/dt, oxygen
consumption (M
O2), and ratexpressure
product were evaluated in conjunction with fluorescent
spectroscopic determinations of intracellular calcium concentrations
(Cai) and the rate of Cai transient decline
during diastole (
Ca). Peak left ventricular
developed pressure and ±dp/dt were significantly lower in the LPS
group. These were completely restored by vesnarinone. There was
significantly slower diastolic calcium removal (increased
Ca) in LPS hearts that was also corrected by vesnarinone; however,
the cytosolic calcium overload characteristic of LPS hearts was only
partially improved. Reduced mechanical inefficiency (the ratio of
rate-pressure product to M
O2) and
myofilament sensitivity to Cai were also significantly
improved by vesnarinone.
ConclusionsAcute endotoxemia caused contractile protein calcium insensitivity, oxygen wastage, and abnormal calcium cycling. Vesnarinone, given in the rescue mode, normalized LPS-induced myocardial dysfunction and partially restored abnormal calcium cycling. Although the mechanisms responsible for these effects require further clarification, it appears that agents such as vesnarinone may be useful to treat inflammatory-induced myocardial dysfunction.
Key Words: calcium contractility proteins inflammation
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |